Autopsy report · NCT03835741

Automated Adjustment of Oxygen on Patient With Acute COPD Exacerbation - FreeO2 HypHop

“The clinical implementation of the system used in the study as well as its routine use limited the possibilities of carrying out this project.”

The sponsor’s own words in the registry.

Life of this trial

• Ran for about 5 years 7 months before it stopped.
• 17 participants enrolled.
• No results are posted on the registry.

Vital statistics

Status

Terminated

Phase

Na

Sponsor

Laval University

Sponsor type

University, hospital or other

Conditions

Oxygen Toxicity; COPD Exacerbation; Hyperoxia; Hypoxemia; Hypoxic Respiratory Failure

Interventions

FreeO2; manual titration

Participants

17

Sites

1

Countries

Canada

Trials that died the same way

• Craniomaxillofacial Allotransplantation
  “It was determined that the study would be integrated into the standard clinical care.” (61% match in meaning)
• Treatment of Balance Disorders in Parkinson's Patients Using SpotOn Balance Glasses
  “The study protocol needed to be modified” (59% match in meaning)
• Inotropic Treatment With Levosimendan (SimdaxR)in Heart Surgery
  “The study was stopped due to difficulties in including patients” (56% match in meaning)

Look deeper

• The official registry record (the source of truth)
• Record history: every change the sponsor made
• Open it in the database

Everything here comes from the current ClinicalTrials.gov record. The timeline uses the record’s dates; dates marked planned are the sponsor’s plans. The cause of death is an automatic, unverified label. This is research information, not medical advice.